{
    "organizations": [],
    "uuid": "044d4933cc8e6cf6c5e39cdaca09b27be178d948",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sandoz-canada-says-ontario-has-add/brief-sandoz-canada-says-ontario-has-added-erelzi-to-its-public-drug-plan-idUSFWN1P40HX",
    "ord_in_thread": 0,
    "title": "BRIEF-Sandoz Canada Says Ontario Has Added Erelzi To Its Public Drug Plan",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 47 PM / Updated 12 minutes ago BRIEF-Sandoz Canada Says Ontario Has Added Erelzi To Its Public Drug Plan Reuters Staff 1 Min Read \nJan 9 (Reuters) - Novartis Ag: \n* SANDOZ CANADA SAYS ONTARIO HAS ADDED ERELZI(TM) (ETANERCEPT) TO ITS PUBLIC DRUG PLAN FOR TREATMENT OF MULTIPLE INFLAMMATORY DISEASESâ€‹ Source text for Eikon: Further company coverage:",
    "published": "2018-01-09T20:47:00.000+02:00",
    "crawled": "2018-01-09T15:01:55.022+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "canada",
        "say",
        "ontario",
        "added",
        "erelzi",
        "public",
        "drug",
        "plan",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "novartis",
        "ag",
        "sandoz",
        "canada",
        "say",
        "ontario",
        "added",
        "erelzi",
        "tm",
        "etanercept",
        "public",
        "drug",
        "plan",
        "treatment",
        "multiple",
        "inflammatory",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}